相关实验视频

Updated: Jun 4, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

通过工程生物材料扩大Ca2+过载,用于协同癌症治疗

Jun-Long Liang¹, Yangyang Cao², Kaiwei Lv¹

¹Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310016, China.

|December 19, 2024

概括

(Ca2+) 过载会触发各种癌细胞死亡途径,提供了一个有前途的治疗策略. 精确控制和理解Ca2+动态的挑战仍然是未来癌症治疗发展的关键领域.

科学领域:

在瘤学瘤学.
生物材料科学生物材料科学
细胞生物学细胞生物学

背景情况:

离子 (Ca2+) 过载是诱导各种癌细胞死亡机制的重要因素,包括亡,烧亡和亡.
在癌症治疗中,Ca2+过载是一种有价值的治疗策略,但临床翻译在精确控制和理解Ca2+动态方面面临挑战.

研究的目的:

在癌症中全面审查Ca2+驱动的细胞内信号通路.
探索基于Ca2+的生物材料在癌症诊断,治疗和免疫治疗中的应用.
讨论Ca2+过载中介癌症疗法的挑战和未来前景.

主要方法:

对Ca2+驱动的细胞内信号通路的文献综述.
在癌症应用中分析基于Ca2+的生物材料 (CaCO3,CaP,CaO2,CaSi,CaF2,CaH2).
对Ca2+过载介导和癌症免疫治疗的组合疗法近期进展的审查.

主要成果:

Ca2+过载激活了多种细胞死亡途径 (细胞亡,热细胞亡,死细胞亡等). 和瘤细胞中的化.
基于Ca2+的生物材料在癌症诊断,治疗和免疫治疗方面具有潜力.
与其他疗法结合的Ca2+过载策略增强了癌症免疫疗法的有效性.

结论:

Ca2+过载是致癌细胞死亡的强有力的诱导剂,也是一个有前途的治疗途径.
克服Ca2+动态控制和理解调节机制的挑战对于临床成功至关重要.
未来的研究应该专注于基于Ca2+的先进材料和组合疗法,以改善瘤学结果.

关键词:

卡2+) 过载的情况.癌症免疫疗法癌症免疫疗法工程生物材料的工程生物材料.热灭菌的发生.协同效应治疗是一种协同效应疗法.

更多相关视频

Biological Compatibility Profile on Biomaterials for Bone Regeneration

Published on: November 16, 2018

Distinctive Capillary Action by Micro-channels in Bone-like Templates can Enhance Recruitment of Cells for Restoration of Large Bony Defect

Distinctive Capillary Action by Micro-channels in Bone-like Templates can Enhance Recruitment of Cells for Restoration of Large Bony Defect

Published on: September 11, 2015

相关概念视频

Calmodulin-dependent Signaling

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...